In his new PSA, Florida surgeon general touts treatments with little track record for COVID

With omicron’s arrival, Dr. Frederick Southwick, an infectious diseases specialist in Gainesville, said the health department’s PSA is particularly “ridiculous.” While monoclonal antibodies have proven to limit severe disease and hospitalizations in people with COVID, the other two treatments Ladapo highlights may be beneficial but the studies have been relatively small.